Project
NIS-KOLON (CNIS793E12201)
Ongoing - recruitment closed · 2022 until 2099
Demmer-Steingruber Ruth, Müller Fiona
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2022
End Date
2099
Financing
Industry
Labels
cancer of colon and small intestine
Brief description/objective
daNIS-3: An open-label, multi-center, phase II platform study evaluating the efficacy and safety of NIS793 and other new investigational drug combinations with standard of care (SOC) anti-cancer therapy for the second line treatment of metastatic colorectal cancer (mCRC)